Approval review of pemigatinib for patients harbouring FGFR2 fusions

by OncoDNA

The FDA have granted priority approval review of pemigatinib for patients harbouring FGFR2 fusions, based on interim data from the phase II FIGHT-202 study showing ORR 36%

Read more

UB Research on Lung Cancer Receives a Grant from the AECC

by Fundació Bosch i Gimpera

The project, entitled "Re-engineering the activated stroma of squamous cell carcinoma of the lung by targeting the aberrant SMAD2-YAP1 fibroblast signaling," aims to study a new therapeutic strategy t...

Read more
Subscribe to Directory
Write an Article

Recent News

¿Por qué no es recomendable llevar la ...

La mejor actitud que podemos adoptar es la de trat...

Exposure to Heat and Cold During Pregnan...

The research team observed changes in head circumf...

Using mobile RNAs to improve Nitrogen a...

AtCDF3 gene induced greater production of sugars a...

Highlight

Eosinófilos. ¿Qué significa tener val...

by Labo'Life

​En nuestro post hablamos sobre este interesante tipo de célula del...

Rethinking Alzheimer’s clinical trials...

by Fundació Clínic per a la Recerca Biomèdica

A paper published in Alzheimer’s & Dementia: The Journal of the Alzh...

Photos Stream